ALX Oncology Inc. (ALXO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ALX Oncology Inc.

    NASDAQ: ALXO · Real-Time Price · USD
    1.22
    0.14 (12.96%)
    At close: Sep 05, 2025, 3:59 PM
    1.17
    -4.04%
    After-hours: Sep 05, 2025, 05:35 PM EDT

    ALX Oncology Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 17.57M 22.41M 48.82M 363.67M
    Short-Term Investments
    		 110.19M 160.33M 217.38M n/a
    Long-Term Investments
    		 3.52M 35.41M 16.7M n/a
    Other Long-Term Assets
    		 267K 7.64M 9.01M 9.69M
    Receivables
    		 892K 1M 1M n/a
    Inventory
    		 n/a n/a -17.7M n/a
    Other Current Assets
    		 5.7M 4.92M 16.7M n/a
    Total Current Assets
    		 134.35M 188.66M 270.97M 367.02M
    Property-Plant & Equipment
    		 9.63M 10.84M 9.81M 3.47M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 13.42M 53.89M 35.52M 13.16M
    Total Assets
    		 147.78M 242.55M 306.49M 380.18M
    Account Payables
    		 4.5M 8.59M 8.07M 3.76M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 435K 1.57M 1.04M 742K
    Other Current Liabilities
    		 7.88M 17.65M 14.46M 444K
    Total Current Liabilities
    		 18.5M 36M 28.32M 15.29M
    Long-Term Debt
    		 9.47M 9.64M 9.39M n/a
    Other Long-Term Liabilities
    		 1.03M 1.22M 5.31M 1.84M
    Total Long-Term Liabilities
    		 15.66M 16.84M 14.7M 1.84M
    Total Liabilities
    		 34.16M 52.84M 43.02M 17.13M
    Total Debt
    		 9.9M 17.2M 10.43M 742K
    Common Stock
    		 53K 50K 41K 41K
    Retained Earnings
    		 -621.12M -486.27M -325.47M -201.99M
    Comprehensive Income
    		 275K 256K -845K n/a
    Shareholders Equity
    		 113.62M 189.71M 263.46M 363.05M
    Total Investments
    		 113.71M 195.74M 234.08M n/a

    Add to Watchlist